Literature DB >> 12826878

Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients.

Jacqueline A Wieneke1, Lester D R Thompson, Clara S Heffess.   

Abstract

Adrenal cortical neoplasms in pediatric patients (<20 years) are rare. The clinical manifestations and biologic behavior of these lesions can be quite distinct from their histologically similar counterparts in the adult population, making pathologic criteria for distinguishing benign from malignant tumors equivocal. We undertook a study of 83 adrenal cortical neoplasms to determine if adult clinical and histologic features can be applied to pediatric patients in an outcome-based analysis. Most of the patients (50 girls and 33 boys) presented with hormone-related symptoms present for a mean of 6.8 months. The tumors ranged in size from 2 to 20 cm (mean 8.8 cm). Histologic parameters examined included capsular and/or vascular invasion, extraadrenal soft tissue extension, growth pattern, cellularity, necrosis, cytoplasmic eosinophilia, nuclear pleomorphism, nuclear-to-cytoplasmic ratio, prominent nucleoli, mitotic figures, atypical mitotic figures, bands of fibrosis, and calcifications. Immunophenotypically, there was reactivity with inhibin, vimentin, CK5, and focally with p53 and Ki-67. All patients underwent adrenalectomy, and 20 patients received adjuvant therapy. All patients with tumors classified as adenomas (n = 9) were alive, without evidence of disease (mean 14.7 years), whereas 21 patients with carcinomas had died with disease (mean 2.4 years). Only 31% of histologically malignant tumors behaved in a clinically malignant fashion. Features associated with an increased probability of a malignant clinical behavior included tumor weight (>400 g), tumor size (>10.5 cm), vena cava invasion, capsular and/or vascular invasion, extension into periadrenal soft tissue, confluent necrosis, severe nuclear atypia, >15 mitotic figures/20 high power fields, and the presence of atypical mitotic figures. Vena cava invasion, necrosis, and increased mitotic activity (>15 mitotic figures/20 high power fields) independently suggest malignant clinical behavior in multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12826878     DOI: 10.1097/00000478-200307000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  58 in total

1.  Management and prognosis of adrenocortical tumors in children: can we find out an appropriate points-scoring system to predict prognosis?

Authors:  Wei Ru; Min Yang; Shan Xu; Minju Li; Daxing Tang
Journal:  Pediatr Surg Int       Date:  2017-03-04       Impact factor: 1.827

2.  Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.

Authors:  Ankur R Sangoi; Mika Fujiwara; Robert B West; Kelli D Montgomery; Joseph V Bonventre; John P Higgins; Robert V Rouse; Neriman Gokden; Jesse K McKenney
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

3.  Pediatric adrenocortical neoplasms: immunohistochemical expression of p57 identifies loss of heterozygosity and abnormal imprinting of the 11p15.5.

Authors:  Isabella Giovannoni; Renata Boldrini; Maria Chiara Benedetti; Alessandro Inserra; Maria Debora De Pasquale; Paola Francalanci
Journal:  Pediatr Res       Date:  2016-11-14       Impact factor: 3.756

Review 4.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

5.  Adrenalectomy for non-neuroblastic pathology in children.

Authors:  Michael D Traynor; Alaa Sada; Geoffrey B Thompson; Christopher R Moir; Irina Bancos; David R Farley; Benzon M Dy; Melanie L Lyden; Elizabeth B Habermann; Travis J McKenzie
Journal:  Pediatr Surg Int       Date:  2019-11-05       Impact factor: 1.827

6.  Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.

Authors:  Gaurav Chatterjee; Shatavisha DasGupta; Gautam Mukherjee; Moumita Sengupta; Paromita Roy; Indu Arun; Chhanda Datta; Prafulla Kumar Mishra; Sugato Banerjee; Uttara Chatterjee
Journal:  Pediatr Surg Int       Date:  2015-04-17       Impact factor: 1.827

Review 7.  [New aspects of tumor pathology of the adrenal glands].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

8.  Factors associated with survival in pediatric adrenocortical carcinoma: An analysis of the National Cancer Data Base (NCDB).

Authors:  Brian C Gulack; Kristy L Rialon; Brian R Englum; Jina Kim; Lindsay J Talbot; Obinna O Adibe; Henry E Rice; Elisabeth T Tracy
Journal:  J Pediatr Surg       Date:  2015-10-23       Impact factor: 2.545

9.  High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.

Authors:  Roberto Rosati; Flavia Cerrato; Mabrouka Doghman; Mara A D Pianovski; Guilherme A Parise; Gislaine Custódio; Gerard P Zambetti; Raul C Ribeiro; Andrea Riccio; Bonald C Figueiredo; Enzo Lalli
Journal:  Cancer Genet Cytogenet       Date:  2008-10

10.  Histone mRNA in situ hybridization and Ki 67 immunohistochemistry in pediatric adrenocortical tumors.

Authors:  Diclehan Orhan; Gülsev Kale; Melda Cağlar; Safiye Göğüş; Ergun Karaağaoğlu
Journal:  Virchows Arch       Date:  2006-02-18       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.